324 related articles for article (PubMed ID: 33449145)
1. An emerging potential of metabolomics in multiple sclerosis: a comprehensive overview.
Zahoor I; Rui B; Khan J; Datta I; Giri S
Cell Mol Life Sci; 2021 Apr; 78(7):3181-3203. PubMed ID: 33449145
[TBL] [Abstract][Full Text] [Related]
2. Metabolomics as a promising tool for improving understanding of multiple sclerosis: A review of recent advances.
Liu Z; Waters J; Rui B
Biomed J; 2022 Aug; 45(4):594-606. PubMed ID: 35042018
[TBL] [Abstract][Full Text] [Related]
3. Metabolomics in multiple sclerosis disease course and progression.
Bhargava P; Anthony DC
Mult Scler; 2020 Apr; 26(5):591-598. PubMed ID: 31965880
[TBL] [Abstract][Full Text] [Related]
4. Metabolome-based signature of disease pathology in MS.
Andersen SL; Briggs FBS; Winnike JH; Natanzon Y; Maichle S; Knagge KJ; Newby LK; Gregory SG
Mult Scler Relat Disord; 2019 Jun; 31():12-21. PubMed ID: 30877925
[TBL] [Abstract][Full Text] [Related]
5. Urinary and Plasma Metabolomics Identify the Distinct Metabolic Profile of Disease State in Chronic Mouse Model of Multiple Sclerosis.
Singh J; Cerghet M; Poisson LM; Datta I; Labuzek K; Suhail H; Rattan R; Giri S
J Neuroimmune Pharmacol; 2019 Jun; 14(2):241-250. PubMed ID: 30315511
[TBL] [Abstract][Full Text] [Related]
6. Kynurenine pathway metabolomics predicts and provides mechanistic insight into multiple sclerosis progression.
Lim CK; Bilgin A; Lovejoy DB; Tan V; Bustamante S; Taylor BV; Bessede A; Brew BJ; Guillemin GJ
Sci Rep; 2017 Feb; 7():41473. PubMed ID: 28155867
[TBL] [Abstract][Full Text] [Related]
7. Contribution of Metabolomics to Multiple Sclerosis Diagnosis, Prognosis and Treatment.
Rispoli MG; Valentinuzzi S; De Luca G; Del Boccio P; Federici L; Di Ioia M; Digiovanni A; Grasso EA; Pozzilli V; Villani A; Chiarelli AM; Onofrj M; Wise RG; Pieragostino D; Tomassini V
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681773
[TBL] [Abstract][Full Text] [Related]
8. A Urinary Metabolic Signature for Multiple Sclerosis and Neuromyelitis Optica.
Gebregiworgis T; Nielsen HH; Massilamany C; Gangaplara A; Reddy J; Illes Z; Powers R
J Proteome Res; 2016 Feb; 15(2):659-66. PubMed ID: 26759122
[TBL] [Abstract][Full Text] [Related]
9. Metabolomics and correlation network analyses of core biomarkers in type 2 diabetes.
Lin W; Wang M; Chen M; Zheng X; Wu Y; Gao D; Yang Z; Tian Z
Amino Acids; 2020 Sep; 52(9):1307-1317. PubMed ID: 32930872
[TBL] [Abstract][Full Text] [Related]
10. Brain energy metabolism and multiple sclerosis: progress and prospects.
Park SJ; Choi JW
Arch Pharm Res; 2020 Oct; 43(10):1017-1030. PubMed ID: 33119885
[TBL] [Abstract][Full Text] [Related]
11. Metabolomics in multiple sclerosis.
Bhargava P; Calabresi PA
Mult Scler; 2016 Apr; 22(4):451-60. PubMed ID: 26754801
[TBL] [Abstract][Full Text] [Related]
12. Profile of Circulatory Metabolites in a Relapsing-remitting Animal Model of Multiple Sclerosis using Global Metabolomics.
Mangalam A; Poisson L; Nemutlu E; Datta I; Denic A; Dzeja P; Rodriguez M; Rattan R; Giri S
J Clin Cell Immunol; 2013 Jun; 4():. PubMed ID: 24273690
[TBL] [Abstract][Full Text] [Related]
13. Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis.
Poddighe S; Murgia F; Lorefice L; Liggi S; Cocco E; Marrosu MG; Atzori L
Int J Biochem Cell Biol; 2017 Dec; 93():148-155. PubMed ID: 28720279
[TBL] [Abstract][Full Text] [Related]
14. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
Wu N; Wang W; Yi M; Cheng S; Wang D
Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
[TBL] [Abstract][Full Text] [Related]
15. Untargeted Plasma Metabolomics Identifies Endogenous Metabolite with Drug-like Properties in Chronic Animal Model of Multiple Sclerosis.
Poisson LM; Suhail H; Singh J; Datta I; Denic A; Labuzek K; Hoda MN; Shankar A; Kumar A; Cerghet M; Elias S; Mohney RP; Rodriguez M; Rattan R; Mangalam AK; Giri S
J Biol Chem; 2015 Dec; 290(52):30697-712. PubMed ID: 26546682
[TBL] [Abstract][Full Text] [Related]
16. Deciphering the biological effects of acupuncture treatment modulating multiple metabolism pathways.
Zhang A; Yan G; Sun H; Cheng W; Meng X; Liu L; Xie N; Wang X
Sci Rep; 2016 Feb; 6():19942. PubMed ID: 26879284
[TBL] [Abstract][Full Text] [Related]
17. The role of the Human Metabolome Database in inborn errors of metabolism.
Mandal R; Chamot D; Wishart DS
J Inherit Metab Dis; 2018 May; 41(3):329-336. PubMed ID: 29663269
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Approaches to Decipher Mechanisms Underlying Pathogenesis in Multiple Sclerosis Patients.
Singh V; Tripathi A; Dutta R
Proteomics; 2019 Aug; 19(16):e1800335. PubMed ID: 31119864
[TBL] [Abstract][Full Text] [Related]
19. Challenges and emergent solutions for LC-MS/MS based untargeted metabolomics in diseases.
Cui L; Lu H; Lee YH
Mass Spectrom Rev; 2018 Nov; 37(6):772-792. PubMed ID: 29486047
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
